Takara spins off biotech unit
Tuesday, 02 April, 2002
Japanese liquor maker Takara Shuzo has stepped up its push to make a name for itself in the biotechnology sector by separating its bio-related activities into a new company.
The split, which was completed on Monday (April 1) as the new Japanese fiscal year began, has resulted in the formation of two companies, Takara Shuzo Co Ltd and Takara Biomedical Co Ltd, under a single holding company, Takara Holdings Inc.
Otsu, Japan based Takara Biomedical includes Dragon Genomics, a genome analysis center formed last year in western Japan.
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...
CRISPR molecular scissors can introduce genetic defects
CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases,...